Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) moved one step closer to potentially selling doses of their coronavirus vaccine, BNT162b2, to EU member states. Investors have known since mid-July that the duo was in talks with the European Commission. But, as governments are apt to do, it's taken awhile to get the deal done.